Prosecution Insights
Last updated: October 25, 2026

Incando Therapeutics Pte. Ltd.

Technology area: Medical Devices & Mechanical Engineering

2 pending office actions • 2 art units • 2 examiners • 0 of 2 (0%) have an AI response strategy ready

Analysis

Incando Therapeutics Pte. Ltd. operates a patent portfolio within the Medical Devices & Mechanical Engineering technology area. There are currently 2 pending office actions associated with this company. This count indicates a focused set of active patent applications undergoing review for medical and mechanical innovations.

The prosecution of these filings involves 2 distinct examiners and is localized within 1 distinct art unit. This concentration in 1 distinct art unit suggests that the company's intellectual property is categorized within a specific technical field. The use of 2 distinct examiners means that each of the 2 pending office actions is being evaluated by a different official, requiring separate legal strategies.

FARAH, AHMED M is the busiest examiner for this portfolio, with 1 busiest examiner pending office action. This examiner is responsible for 1 of the 2 pending office actions currently active. To advance the portfolio, practitioners must navigate the specific requirements of 2 distinct examiners while operating within the technical constraints of the Medical Devices & Mechanical Engineering art unit.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Portfolio Summary

2
Total Pending OAs
1
Non-Final OAs
1
Final Rejections
0
Advisory / Quayle

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

0
Hard (0%)
2
Medium (100%)
0
Easy (0%)
0
Unknown (0%)

Rejection Statute Mix

BucketCases
§103 only1 (50%)
Double-patenting + other1 (50%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

0
Life Sciences
0% of docket
0
Information Tech
0% of docket
0
Communications
0% of docket
0
Semiconductors
0% of docket
2
Mechanical / Eng
100% of docket
0
Business / Other
0% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

20 h
Manual time on pending OAs
4 h
Time saved (low, 20%)
7 h
Time saved (mid, 35%)
0.2 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
FARAH, AHMED M 1 78.9% +18.9%
JENNESS, NATHAN JAY 1 54.0% +37.4%

Interview Candidates (2)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 2 ordered by deadline are shown.

App #TitleExaminerDue in
18911671 METHODS AND APPARATUS FOR PHOTOTHERAPY FARAH, AHMED M —
18372423 REPEATED PHOTODYNAMIC THERAPY USING PHOTOSENSITIZING AGENT JENNESS, NATHAN JAY —

Top Art Units

Art UnitApps
3792 1
3733 1

Pending Office Actions

App #TitleExaminerArt UnitStatutesStatusDue inAIFiled
18911671 METHODS AND APPARATUS FOR PHOTOTHERAPY FARAH, AHMED M 3792 §112DP Non-Final OA — Pending Oct 10, 2024
18372423 REPEATED PHOTODYNAMIC THERAPY USING PHOTOSENSITIZING AGENT JENNESS, NATHAN JAY 3733 §103 Final Rejection — Pending Sep 25, 2023

Managing Incando Therapeutics Pte. Ltd.'s Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Frequently Asked Questions

How many pending USPTO office actions does Incando Therapeutics Pte. Ltd. have?

Incando Therapeutics Pte. Ltd. has 2 pending office actions as of October 2026, spread across 2 art units and 2 examiners.

Which USPTO examiner handles the most Incando Therapeutics Pte. Ltd. applications?

Ahmed M Farah has the most, with 1 of Incando Therapeutics Pte. Ltd.'s pending office actions.

What technology area are Incando Therapeutics Pte. Ltd.'s patent applications in?

Mostly Medical Devices & Mechanical Engineering (USPTO Tech Center 3700), based on where its pending office actions are examined.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month